Skip to main content

Series C Biotechnology Companies

Explore 167 biotechnology startups that raised series c funding. Access verified founder contact information and fundraising data.

Total Companies
167
Total Funding
$1.6B
Avg Funding
$65.7M
Cities
15

Export 167 Series C Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Oxford, United Kingdom
$44.6M
raised

Genomics plc aiming to lead the genomic transformation of healthcare.

Jan 2024
Series C

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$200.0M
raised

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.

Jan 2026
Series C

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$207.5M
raised

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Jan 2025
Series C

Founder Contacts

30,000+ verified contacts

Menlo Park, United States
$100.0M
raised

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Jan 2023
Series C

Founder Contacts

30,000+ verified contacts

Écully, France
$138.6M
raised

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Jan 2023
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 167 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Mystic, United States
$10.0M
raised

Enko Chem utilizes predictive analytics to develop products for farmers that protect their crops from pests and disease.

Jan 2023
Series C

Founder Contacts

30,000+ verified contacts

Mountain View, United States

Athelas develops technology to monitor chronically ill patients in their homes.

Jan 2022
Series C

Founder Contacts

30,000+ verified contacts

Menlo Park, United States
$24.0M
raised

Antheia uses synthetic biology to produce biosynthetic KSMs and APIs for essential medicines through engineered microbial fermentation.

Jan 2026
Series C

Founder Contacts

30,000+ verified contacts

London, United Kingdom
$52.0M
raised

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

Dec 2022
Series C

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom
$33.5M
raised

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

Jan 2024
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 167 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United Kingdom
$4.7M
raised

Metrion Biosciences is a Contract Research Organization.

Dec 2023
Series C

Founder Contacts

30,000+ verified contacts

Somerville, United States

Generate Biomedicines is a biotech company that combines biology, machine learning, and biological engineering to create biomedicines.

Dec 2024
Series C

Founder Contacts

30,000+ verified contacts

South San Francisco, United States
$100.0M
raised

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

Dec 2024
Series C

Founder Contacts

30,000+ verified contacts

Naarden, The Netherlands
$80.0M
raised

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Dec 2021
Series C

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Culture Biosciences provides automated systems for bioprocess development that help optimize biological products and processes.

Dec 2025
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 167 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$60.0M
raised

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Dec 2022
Series C

Founder Contacts

30,000+ verified contacts

Boston, United States
$48.0M
raised

SmartLabs builds and operates labs, including multi-use R&D labs, vivariums, process development, and manufacturing suites.

Jan 2024
Series C

Founder Contacts

30,000+ verified contacts

San Diego, United States
$10.0M
raised

Certis Oncology Solutions is a precision oncology and translational science company serving patients, oncologists and drug developers

Jan 2024
Series C

Founder Contacts

30,000+ verified contacts

Seattle, United States
$52.8M
raised

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

Nov 2022
Series C

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$92.0M
raised

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

Jan 2025
Series C

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 167 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Seattle, United States
$100.0M
raised

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Jan 2025
Series C

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom
$12.0M
raised

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Jan 2026
Series C

Founder Contacts

30,000+ verified contacts

Boston, United States
$100.0M
raised

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Nov 2021
Series C

Founder Contacts

30,000+ verified contacts

San Diego, United States
$120.0M
raised

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Nov 2022
Series C

Founder Contacts

30,000+ verified contacts

Montreal, Canada
$53.0M
raised

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

Nov 2024
Series C

Founder Contacts

30,000+ verified contacts

Showing 126 to 150 of 167 companies

Ready to Connect with Series C Biotechnology Startups?

Get verified founder emails, funding details, and company data for 167 series c biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

167 Biotechnology Series C Startups (July 2026) — Page 6 | VCBacked